Tubacex, S.A.

BME:TUB Stock Report

Market Cap: €408.0m

Tubacex Balance Sheet Health

Financial Health criteria checks 1/6

Tubacex has a total shareholder equity of €289.9M and total debt of €582.0M, which brings its debt-to-equity ratio to 200.8%. Its total assets and total liabilities are €1.2B and €958.0M respectively. Tubacex's EBIT is €66.1M making its interest coverage ratio 1.8. It has cash and short-term investments of €139.2M.

Key information

200.8%

Debt to equity ratio

€582.00m

Debt

Interest coverage ratio1.8x
Cash€139.20m
Equity€289.90m
Total liabilities€958.00m
Total assets€1.25b

Recent financial health updates

These 4 Measures Indicate That Tubacex (BME:TUB) Is Using Debt Extensively

Jul 24
These 4 Measures Indicate That Tubacex (BME:TUB) Is Using Debt Extensively

Is Tubacex (BME:TUB) A Risky Investment?

Apr 05
Is Tubacex (BME:TUB) A Risky Investment?

Is Tubacex (BME:TUB) Using Too Much Debt?

Aug 13
Is Tubacex (BME:TUB) Using Too Much Debt?

Is Tubacex (BME:TUB) A Risky Investment?

Sep 30
Is Tubacex (BME:TUB) A Risky Investment?

Does Tubacex (BME:TUB) Have A Healthy Balance Sheet?

May 14
Does Tubacex (BME:TUB) Have A Healthy Balance Sheet?

Is Tubacex (BME:TUB) Using Debt In A Risky Way?

Dec 14
Is Tubacex (BME:TUB) Using Debt In A Risky Way?

Recent updates

Tubacex, S.A.'s (BME:TUB) Shares Leap 25% Yet They're Still Not Telling The Full Story

Oct 09
Tubacex, S.A.'s (BME:TUB) Shares Leap 25% Yet They're Still Not Telling The Full Story

Investors Will Want Tubacex's (BME:TUB) Growth In ROCE To Persist

Sep 18
Investors Will Want Tubacex's (BME:TUB) Growth In ROCE To Persist

These 4 Measures Indicate That Tubacex (BME:TUB) Is Using Debt Extensively

Jul 24
These 4 Measures Indicate That Tubacex (BME:TUB) Is Using Debt Extensively

Is Tubacex (BME:TUB) A Risky Investment?

Apr 05
Is Tubacex (BME:TUB) A Risky Investment?

Is Tubacex (BME:TUB) Using Too Much Debt?

Aug 13
Is Tubacex (BME:TUB) Using Too Much Debt?

Is There An Opportunity With Tubacex, S.A.'s (BME:TUB) 43% Undervaluation?

Jul 06
Is There An Opportunity With Tubacex, S.A.'s (BME:TUB) 43% Undervaluation?

Is Tubacex (BME:TUB) A Risky Investment?

Sep 30
Is Tubacex (BME:TUB) A Risky Investment?

Tubacex, S.A. (BME:TUB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Jul 31
Tubacex, S.A. (BME:TUB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Time To Worry? Analysts Are Downgrading Their Tubacex, S.A. (BME:TUB) Outlook

Jul 29
Time To Worry? Analysts Are Downgrading Their Tubacex, S.A. (BME:TUB) Outlook

Does Tubacex (BME:TUB) Have A Healthy Balance Sheet?

May 14
Does Tubacex (BME:TUB) Have A Healthy Balance Sheet?

What Is The Ownership Structure Like For Tubacex, S.A. (BME:TUB)?

Mar 15
What Is The Ownership Structure Like For Tubacex, S.A. (BME:TUB)?

Reflecting on Tubacex's (BME:TUB) Share Price Returns Over The Last Three Years

Feb 07
Reflecting on Tubacex's (BME:TUB) Share Price Returns Over The Last Three Years

Is Tubacex (BME:TUB) Using Debt In A Risky Way?

Dec 14
Is Tubacex (BME:TUB) Using Debt In A Risky Way?

A Rising Share Price Has Us Looking Closely At Tubacex, S.A.'s (BME:TUB) P/E Ratio

Jun 21
A Rising Share Price Has Us Looking Closely At Tubacex, S.A.'s (BME:TUB) P/E Ratio

Financial Position Analysis

Short Term Liabilities: TUB's short term assets (€708.2M) do not cover its short term liabilities (€715.0M).

Long Term Liabilities: TUB's short term assets (€708.2M) exceed its long term liabilities (€243.0M).

Debt to Equity History and Analysis

Debt Level: TUB's net debt to equity ratio (152.7%) is considered high.

Reducing Debt: TUB's debt to equity ratio has increased from 144.7% to 200.8% over the past 5 years.

Debt Coverage: TUB's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: TUB's interest payments on its debt are not well covered by EBIT (1.8x coverage).

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 11:52
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tubacex, S.A. is covered by 20 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
César Sánchez-Grande BergonAhorro Corporación
Bruno BessaBanco BPI, S.A.
Francisco Rodríguez SánchezBanco de Sabadell. S.A.